Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Drug Firms Increasing Investment in R&D
December 10, 2001
- Sales of 30 Major Makers Up 2.3%, Profits Up 55.9%
December 10, 2001
- PhRMA Calls For Abolition of Re-pricing System
December 10, 2001
- Nippon Roche, GSK/IPF Hold Seminars on Influenza
December 3, 2001
- Otsuka Signs Contract with Celera Genomics for Genomic Database
December 3, 2001
- OTC NEWS IN BRIEF
December 3, 2001
- Kyorin Beefs Up Globalization by Forming Subsidiary in Europe
December 3, 2001
- Semi-annual Sales of OTC Drugs Up 1.1% from Last Year: INTAGE Survey
December 3, 2001
- REGULATORY NEWS IN BRIEF
December 3, 2001
- Current Price Gap Estimated to Be About 8%
December 3, 2001
- Decreases in Medical Fees Not Proposed by Gov't WT
December 3, 2001
- Ono to Start Overseas Business in Earnest: President Matsumoto
December 3, 2001
- Chuikyo Hearing: Industry Insists on Market Price Principle
December 3, 2001
- DIAGNOSTIC NEWS IN BRIEF
December 3, 2001
- 5 New Drugs Including Synagis, Leustatin Recommended for Approval
December 3, 2001
- Bayer Medical: Smear Sampling, Staining Device ADVIA S60
December 3, 2001
- CORPORATE ROUNDUP NEWS IN BRIEF -3-
December 3, 2001
- Bayer Medical: Myocardial Infarction Marker Kit
December 3, 2001
- CORPORATE ROUNDUP NEWS IN BRIEF -2-
December 3, 2001
- Shionogi Ties Up with SRL in Lab Test Business
December 3, 2001
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…